Linked Data API

Filter

These are the filters currently being used to limit the search results. Click on the remove filter icon to remove the filter.

tabling member constituency	Eastbourne
max date tabled	2024-01-15
uin	198515
version	1

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are shown at the top of the list. Click on remove this sort to remove a sort and or to reverse the current sort order. Click on the remove all sorting icon to remove all the sorting. Note that sorting can significantly slow down the loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined views, but starred properties are always present no matter what the view. You can star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

Items per page

Choose how many items to view on each page. The more items you view, the longer the page will take to load.

Show Search Form

Search Results

registered interest

date

exactly:

or between:
and

answering body

answering dept id

answering dept short name

answering dept sort name

hansard heading

house id

legislature


pref label

question text

tabling member constituency

tabling member printed

uin

answer

is ministerial correction

date of answer

exactly:

or between:
and

answer text

answering member constituency

answering member printed

question first answered

answering member


label

tabling member


label

1659334

registered interest

date

08/09/2023

answering body

Department of Health and Social Care

answering dept id

answering dept short name

Health and Social Care

answering dept sort name

Health and Social Care

hansard heading

Brain Cancer: Immunotherapy

house id

legislature

25259

pref label	House of Commons

question text

To ask the Secretary of State for Health and Social Care, whether his Department plans to make an assessment of the effectiveness of immunotherapy as a treatment for brain cancer; and if he will make a statement.

tabling member constituency

Eastbourne

tabling member printed

Caroline Ansell

uin

198515

answer

is ministerial correction

date of answer

15/09/2023

answer text

<p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on whether medicines represent a clinically and cost-effective use of resources. All new medicines, including immunotherapies, are appraised by NICE within their licensed indications, and the NHS in England is legally required to fund medicines recommended by NICE.</p><p>NICE is currently developing guidance on the immunotherapy dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 to 17. If this is recommended for use on the NHS, it will be eligible for funding through the Cancer Drugs Fund from the point that NICE issues positive draft guidance.</p>

answering member constituency

Colchester

answering member printed

Will Quince

question first answered

15/09/2023 09:55:59

answering member

4423

label	Biography information for Will Quince

tabling member

4512

label	Biography information for Caroline Ansell